2006
DOI: 10.1038/sj.ijir.3901457
|View full text |Cite|
|
Sign up to set email alerts
|

Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve stimulation

Abstract: In this study, we evaluated the effect of lower urinary tract dysfunction and its neuromodulative therapy on sexual functioning. We studied 121 patients with an overactive bladder (OAB) (N ¼ 83), chronic pelvic pain (N ¼ 23) and nonobstructive retention (N ¼ 15), which were treated with neuromodulation (i.e. percutaneous tibial nerve stimulation, PTNS). To obtain information on their sexual function, a self-administered standardized questionnaire was filled out before therapy as well as after 12 weeks of treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 14 publications
1
29
1
Order By: Relevance
“…Most of the patients reported having sexual function disorder before treatment, but they were found to have more desire, more frequent intercourse and be more satisfied in their sexual lives after treatment. Although positive changes after treatment were detected in women with overactive bladder, no statistically significant difference was found in patients with CPP [24]. Women’s total FSFI scores obtained in our study were 20.87 ± 6.76 for the experimental group before treatment and 21.47 ± 5.87 for the women in the control group.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…Most of the patients reported having sexual function disorder before treatment, but they were found to have more desire, more frequent intercourse and be more satisfied in their sexual lives after treatment. Although positive changes after treatment were detected in women with overactive bladder, no statistically significant difference was found in patients with CPP [24]. Women’s total FSFI scores obtained in our study were 20.87 ± 6.76 for the experimental group before treatment and 21.47 ± 5.87 for the women in the control group.…”
Section: Discussionmentioning
confidence: 75%
“…Verit et al [23] found that women with CPP had sexual pain disorder most frequently (74.3%) followed by hypoactive sexual desire disorder (53.8%). Van Balken et al [24] claimed that the sexual lives of many patients with lower urinary system function disorder improve after treatment (PTNS) and they have fewer urological complaints. Their multicentric prospective study included 121 patients (45 men, 76 women): 83 with overactive bladder (22 men, 61 women), 23 with CPP (17 men, 6 women) and 15 with nonobstructive urinary retention (9 men, 6 women).…”
Section: Discussionmentioning
confidence: 99%
“…The NSF does not differentiate between leakage at penetration or during organism. This questionnaire is originally developed to measure the influence of medication on sexual functioning, however is also been used in treatment modalities like percutaneous tibial nerve stimulation [26]. The severity of symptoms is quantified using a five-point Likert scale.…”
Section: Methodsmentioning
confidence: 99%
“…At least three other treatment studies have included assessment of sexual dysfunction (see Table 3). In the first study, percutanous tibial nerve stimulation was somewhat successful for pain in both men and women, but not for sexual dysfunction (van Balken, Vergunst, & Bemelmans, 2006). In the second study, Lee, West, & Wilson (2005) compared sertraline to a placebo, but the results were non-significant.…”
Section: Treatment Of Other Sexual Dysfunctionmentioning
confidence: 98%